123 related articles for article (PubMed ID: 8886853)
1. Effect of cortisol and ACTH on corticosteroid-suppressed peripheral blood natural killer cells from healthy volunteers and patients with Crohn's disease.
van Ierssel GJ; Mieremet-Ooms MA; van der Zon AM; van Hogezand RA; Wagtmans MJ; van der Sluys Veer A; Lamers CB; Verspaget HW
Immunopharmacology; 1996 Sep; 34(2-3):97-104. PubMed ID: 8886853
[TBL] [Abstract][Full Text] [Related]
2. Suppression of intestinal mucosal natural killer cells by corticosteroids.
Van Ierssel AJ; Mieremet-Ooms MA; Van der Zon JM; Van Hogezand RA; Griffioen G; Lamers CB; Verspaget HW
Aliment Pharmacol Ther; 1997 Apr; 11(2):347-53. PubMed ID: 9146774
[TBL] [Abstract][Full Text] [Related]
3. Contribution of plasma cortisol to corticosteroid-suppressed peripheral blood natural killer cell activity in Crohn's disease.
van Ierssel GJ; van der Sluys Veer A; Verspaget HW; Griffioen G; van Hogezand RA; Lamers CB
Immunopharmacology; 1995 Feb; 29(1):11-7. PubMed ID: 7768667
[TBL] [Abstract][Full Text] [Related]
4. Budesonide and prednisolone suppress peripheral blood natural killer cells in Crohn's disease.
Van Ierssel AJ; Van der Sluys Veer A; Verspaget HW; Griffioen G; Van Hogezand RA; Lamers CB
Aliment Pharmacol Ther; 1995 Apr; 9(2):173-8. PubMed ID: 7605858
[TBL] [Abstract][Full Text] [Related]
5. Interplay in vitro between ACTH, beta-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity.
Gatti G; Masera RG; Pallavicini L; Sartori ML; Staurenghi A; Orlandi F; Angeli A
Brain Behav Immun; 1993 Mar; 7(1):16-28. PubMed ID: 8386029
[TBL] [Abstract][Full Text] [Related]
6. Adrenocorticotropin stimulates natural killer cell activity.
McGlone JJ; Lumpkin EA; Norman RL
Endocrinology; 1991 Sep; 129(3):1653-8. PubMed ID: 1651855
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell activity in the peripheral blood of patients with Cushing's syndrome.
Masera RG; Staurenghi A; Sartori ML; Angeli A
Eur J Endocrinol; 1999 Apr; 140(4):299-306. PubMed ID: 10097248
[TBL] [Abstract][Full Text] [Related]
8. Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group.
Campieri M; Ferguson A; Doe W; Persson T; Nilsson LG
Gut; 1997 Aug; 41(2):209-14. PubMed ID: 9301500
[TBL] [Abstract][Full Text] [Related]
9. A comparison of budesonide with prednisolone for active Crohn's disease.
Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen OO; Lorenz-Meyer H
N Engl J Med; 1994 Sep; 331(13):842-5. PubMed ID: 8078530
[TBL] [Abstract][Full Text] [Related]
10. In vivo glucocorticoid effects on porcine natural killer cell activity and circulating leukocytes.
Salak-Johnson JL; McGlone JJ; Norman RL
J Anim Sci; 1996 Mar; 74(3):584-92. PubMed ID: 8707714
[TBL] [Abstract][Full Text] [Related]
11. Adrenocortical suppression by topically applied corticosteroids in healthy dogs.
Zenoble RD; Kemppainen RJ
J Am Vet Med Assoc; 1987 Sep; 191(6):685-8. PubMed ID: 2824410
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibitory effects of stress hormones on natural killer (NK) cell activity of lymphocytes from AIDS patients.
Nair MP; Saravolatz LD; Schwartz SA
Immunol Invest; 1995 Aug; 24(5):689-99. PubMed ID: 8543334
[TBL] [Abstract][Full Text] [Related]
13. Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial.
Escher JC;
Eur J Gastroenterol Hepatol; 2004 Jan; 16(1):47-54. PubMed ID: 15095852
[TBL] [Abstract][Full Text] [Related]
14. Effect of endogenous cortisol levels on natural killer cell activity in healthy humans.
Bodner G; Ho A; Kreek MJ
Brain Behav Immun; 1998 Dec; 12(4):285-96. PubMed ID: 10080858
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease.
Schoon EJ; Bollani S; Mills PR; Israeli E; Felsenberg D; Ljunghall S; Persson T; Haptén-White L; Graffner H; Bianchi Porro G; Vatn M; Stockbrügger RW;
Clin Gastroenterol Hepatol; 2005 Feb; 3(2):113-21. PubMed ID: 15704045
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by cortisol of human natural killer (NK) cell activity.
Gatti G; Cavallo R; Sartori ML; del Ponte D; Masera R; Salvadori A; Carignola R; Angeli A
J Steroid Biochem; 1987 Jan; 26(1):49-58. PubMed ID: 2434732
[TBL] [Abstract][Full Text] [Related]
17. Adrenocortical steroid requirements for initiation of ACTH-dependent hypertension in sheep.
Spence CD; Coghlan JP; Denton DA; Mills EH; Whitworth JA; Scoggins BA
Clin Exp Pharmacol Physiol; 1989 Oct; 16(10):759-72. PubMed ID: 2558826
[TBL] [Abstract][Full Text] [Related]
18. Human kidney 11 beta-hydroxysteroid dehydrogenase: regulation by adrenocorticotropin?
Diederich S; Quinkler M; Miller K; Heilmann P; Schoneshofer M; Oelkers W
Eur J Endocrinol; 1996 Mar; 134(3):301-7. PubMed ID: 8616526
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous and interferon-induced natural cytotoxicity in Crohn's disease.
Müller C; Knoflach P; Smetana P; Meisinger V; Zielinski CC
Digestion; 1988; 39(1):26-34. PubMed ID: 3135216
[TBL] [Abstract][Full Text] [Related]
20. Comparison of methods for evaluation of the suppressive effects of prednisolone on the HPA axis and bone turnover: changes in s-DHEAS are as sensitive as the ACTH test.
Gruvstad E; Hedner LP; Höglund P; Luts A; Norjavaara E
Int J Clin Pharmacol Ther; 2014 Jan; 52(1):15-26. PubMed ID: 24120714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
